Cargando…
Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
Following the outbreak of novel severe acute respiratory syndrome (SARS)-coronavirus (CoV)2, the majority of nations are struggling with countermeasures to fight infection, prevent spread and improve patient survival. Considering that the pandemic is a recent event, no large clinical trials have bee...
Autores principales: | Clemente, Valentino, D’Arcy, Padraig, Bazzaro, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278987/ https://www.ncbi.nlm.nih.gov/pubmed/32429099 http://dx.doi.org/10.3390/ijms21103492 |
Ejemplares similares
-
Deubiquitinating Enzymes Related to Autophagy: New Therapeutic Opportunities?
por: Jacomin, Anne-Claire, et al.
Publicado: (2018) -
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
por: Poondla, Naresh, et al.
Publicado: (2019) -
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells
por: Vogel, Rachel Isaksson, et al.
Publicado: (2015) -
Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
por: Antao, Ainsley Mike, et al.
Publicado: (2020) -
Deubiquitinating enzymes as oncotargets
por: McClurg, Urszula L., et al.
Publicado: (2015)